Searched for
TORRENT PHARMACEUTICALS REVENUE
Torrent Pharmaceuticals Q1 Results: Profit rises 3% to Rs 566 croreTorrent Pharmaceuticals announced a robust profit after tax of Rs 566 crore for the first quarter, showcasing impressive growth. Revenue so...- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Owning an ecosystem is sometimes the better approach: 21 stocks from the energy ecosystem, 9 with upside potential of over 13%Faced with a rising sector, the instinct is to find the best stock in it. The single name that will best ride the wave. In an ecosystem lik...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Torrent Pharmaceuticals Q4 Results: Net profit rises 11% to Rs 498 croreTorrent Pharmaceuticals Ltd on Tuesday reported an 11 per cent rise in consolidated net profit at Rs 498 crore in the fourth quarter ended ...
- Pharmaceutical's promoter sells 2.9% stake for Rs 3,086 croreAccording to the bulk deal data available with the BSE, Torrent Investments Pvt Ltd sold a total of 99.44 lakh shares or 2.94 per cent stak...
- Buy Torrent Pharma, target price Rs 1750: Prabhudas LilladherTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 51741.54 Crore) operating in...
- Buy Torrent Pharmaceuticals, target price Rs 3250: Prabhudas LilladherTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 25328.41 Crore) operating in...
- Buy Torrent Pharmaceuticals, target price Rs 3250: ICICI DirectTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 49159.20 Crore) operating in...
- Buy Torrent Pharmaceuticals, target price Rs 2990: HDFC SecuritiesTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 48799.60 Crore) operating in...
- Buy Torrent Pharmaceuticals, target price Rs 3226: ICICI SecuritiesTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 47840.11 Crore) operating in...
- Buy Torrent Pharmaceuticals, target price Rs 3300: EdelweissTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 52008.06 Crore) operating in...
- Sell Torrent Pharmaceuticals, target Rs 1275: Anand RathiSell Torrent Pharmaceuticals Ltd. at a price target of Rs 1275.0 .
- Buy Torrent Pharmaceuticals Ltd. target Rs 1485.0 : Sacchitanand UttekarBuy Torrent Pharmaceuticals Ltd. at a price target of Rs 1485.0 and a stoploss at Rs 1414 from entry point.
Load More
